Standard screening guidelines cover a limited number of cancers and typically aren’t recommended until later in life. As a result, many cancers go undetected until symptoms develop. We built our approach around that gap.

By combining advanced imaging, blood testing, and genetic testing, we can evaluate a broader range of potential health risks. Identifying disease earlier may provide you with more treatment options and the potential for better outcomes.